EICHOR
● Active Not Recruiting
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1 · Sponsor: vTv Therapeutics
About this study
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (52)
| Scottsdale Clinical Trials | Scottsdale, Arizona, United States | — |
| Baptist Health Center for Clinical Research | Little Rock, Arkansas, United States | — |
| Amicis Research Center | Granada Hills, California, United States | — |
| AME Clinical Research | Huntington Beach, California, United States | — |
| 310 Clinical Research | Inglewood, California, United States | — |
| Scripps Whittier Diabetes Institute | La Jolla, California, United States | — |
| IMAX Clinical Trials | La Palma, California, United States | — |
| Paradigm Clinical Research - Modesto | Modesto, California, United States | — |
| Paradigm Clinical Research Centers LLC | San Diego, California, United States | — |
| Acclaim Clinical Research | San Diego, California, United States | — |
| The Lundquist Institute | Torrance, California, United States | — |
| Focus Clinical Research | West Hills, California, United States | — |
+ 40 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.